Literature DB >> 4585960

Trimethoprim-sulfamethoxazole: absorption, excretion, and toxicity in six children.

E B Lewin, J O Klein, M Finland.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4585960     DOI: 10.1093/infdis/128.supplement_3.s618

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  8 in total

1.  Bioavailability prediction based on molecular structure for a diverse series of drugs.

Authors:  Joseph V Turner; Desmond J Maddalena; Snezana Agatonovic-Kustrin
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

2.  Comparative efficacy of ampicillin and trimethoprim-sulfamethoxazole in otitis media.

Authors:  G G Cameron; A C Pomahac; M T Johnston
Journal:  Can Med Assoc J       Date:  1975-06-14       Impact factor: 8.262

3.  Pharmacokinetics of trimethoprim-sulfamethoxazole in children.

Authors:  C M Wilfert; L T Gutman
Journal:  Can Med Assoc J       Date:  1975-06-14       Impact factor: 8.262

4.  The dosage of co-trimoxazole in childhood.

Authors:  A S Fowle; A Bye; F Hariri; D Middlemiss; K Naficy
Journal:  Eur J Clin Pharmacol       Date:  1975-04-04       Impact factor: 2.953

Review 5.  Cotrimoxazole and neonatal kernicterus: a review.

Authors:  Baskaran Thyagarajan; Sharad S Deshpande
Journal:  Drug Chem Toxicol       Date:  2013-10-07       Impact factor: 3.356

Review 6.  Pharmacokinetics of antibacterial agents in the CSF of children and adolescents.

Authors:  Amanda K Sullins; Susan M Abdel-Rahman
Journal:  Paediatr Drugs       Date:  2013-04       Impact factor: 3.022

7.  Clinical pharmacokinetics of co-trimoxazole (trimethoprim-sulphamethoxazole).

Authors:  R B Patel; P G Welling
Journal:  Clin Pharmacokinet       Date:  1980 Sep-Oct       Impact factor: 6.447

8.  Clinical pharmacology of intravenously administered trimethoprim-sulfamethoxazole.

Authors:  W E Grose; G P Bodey; T L Loo
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.